Entrada Therapeutics TRDA
NASDAQ TRDA
$5.68 -0.67 (-10.55%)
At close: Oct 1, 2026 · 4:00 PM EDT

Entrada Therapeutics (TRDA) Net Equity Issued and Repurchased (2021 - 2026)

Updated

Entrada Therapeutics' Net Equity Issued and Repurchased was $220,000 in Q2 2026, compared with $20,000 a year earlier and up 120.0% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Entrada Therapeutics' Net Equity Issued and Repurchased was $412,000 through Jun 30, 2026; for FY2025, it was $462,000, down 83.4% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -60.8% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $2.78 million in FY2024 (+134.4%), $1.19 million in FY2023 (+318.0%), $284,000 in FY2022 (-99.9%) and $190.69 million in FY2021 (+282.6%).
  • The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased since Q1 2025.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q3 2023 (growth of 513.3%); the worst was Q2 2025 (a decline of 100.0%).
  • Per Business Quant data, TRDA's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $100,000 (Q1 2026), $84,000 (Q4 2025) and $8,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Entrada Therapeutics 247.25 Mn 247.25 Mn - 220,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 220,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 84,000.00
Sep 30, 2025 8,000.00
Jun 30, 2025 20,000.00
Mar 31, 2025 350,000.00
Dec 31, 2024 -96.83 Mn
Sep 30, 2024 -392,000.00
Jun 30, 2024 99.79 Mn
Mar 31, 2024 206,000.00
Dec 31, 2023 433,000.00
Sep 30, 2023 368,000.00
Jun 30, 2023 -19.02 Mn
Mar 31, 2023 19.41 Mn
Dec 31, 2022 163,000.00
Sep 30, 2022 60,000.00
Jun 30, 2022 11,000.00
Mar 31, 2022 50,000.00
Dec 31, 2021 74.86 Mn
Jun 30, 2021 -417,000.00
API Access

Entrada Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TRDA&period=max&api_key=YOUR_API_KEY